Home
>
National Drug Code (NDC)
>
Hepsera
Hepsera - 46014-0501-1 - (Adefovir Dipivoxil)
Drug Information of Hepsera
| Product NDC: | 46014-0501 |
| Proprietary Name: | Hepsera |
| Non Proprietary Name: | Adefovir Dipivoxil |
| Active Ingredient(s): | 10 mg/1 & nbsp; Adefovir Dipivoxil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Hepsera
| Product NDC: | 46014-0501 |
| Labeler Name: | Excella GmbH |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021449 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020920 |
Package Information of Hepsera
| Package NDC: | 46014-0501-1 |
| Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (46014-0501-1) |
NDC Information of Hepsera
| NDC Code | 46014-0501-1 |
| Proprietary Name | Hepsera |
| Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (46014-0501-1) |
| Product NDC | 46014-0501 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Adefovir Dipivoxil |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20020920 |
| Marketing Category Name | NDA |
| Labeler Name | Excella GmbH |
| Substance Name | ADEFOVIR DIPIVOXIL |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
